J0224 HCPCS Level II code: Injection, lumasiran, 0.5 mg
J0224 is the HCPCS code for “Injection, lumasiran, 0.5 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J0224Injection, lumasiran, 0.5 mg
Short description: Inj. lumasiran, 0.5 mg
HCPCS · United States
Medicare details
The indicators CMS publishes with J0224 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care
- BETOS category
- Other drugs
- Added
- Jul 1, 2021
Where J0224 sits
- 1J codesDrugs administered other than orally
- 2Active code J0224Injection, lumasiran, 0.5 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J0224 mean?
J0224 is the HCPCS code for “Injection, lumasiran, 0.5 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J0224?
CMS lists J0224’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J0224
All J codesJ0218Injection, olipudase alfa-rpcp, 1 mgJ0219Injection, avalglucosidase alfa-ngpt, 4 mgJ0220Injection, alglucosidase alfa, 10 mg, not otherwise specifiedJ0221Injection, alglucosidase alfa, (lumizyme), 10 mgJ0222Injection, patisiran, 0.1 mgJ0223Injection, givosiran, 0.5 mgJ0225Injection, vutrisiran, 1 mgJ0248Injection, remdesivir, 1 mgJ0256Injection, alpha 1 proteinase inhibitor (human), not otherwise specified, 10 mgJ0257Injection, alpha 1 proteinase inhibitor (human), (glassia), 10 mgJ0270Injection, alprostadil, 1.25 mcg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)J0275Alprostadil urethral suppository (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)